Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage

被引:0
|
作者
Maria D. Chermá
Martin Josefsson
Irene Rydberg
Per Woxler
Tomas Trygg
Olle Hollertz
Per A. Gustafsson
机构
[1] National Board of Forensic Medicine,Department of Forensic Genetics and Forensic Toxicology
[2] Linköping University,Department of Clinical Pharmacology and Department of Medical and Health Sciences
[3] Linköping University,Department of Physics, Chemistry and Biology
[4] Linköping University,Department of Medical and Health Sciences
[5] Linköping University Hospital,Department of Dependency
[6] Västervik Hospital,Department of General Psychiatry
[7] Linköping University,Center for Social and Affective Neuroscience Department of Clinical and Experimental Medicine and Department of Child and Adolescent Psychiatry
关键词
Autism Spectrum Disorder; Blood Concentration; Atomoxetine; Oral Fluid; Morning Dose;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:295 / 307
页数:12
相关论文
共 50 条
  • [41] Clinical characteristics of children and adolescents with ADHD with or without methylphenidate prescription at their first diagnostic assessment
    Pietro De Rossi
    Italo Pretelli
    Deny Menghini
    Barbara D’Aiello
    Silvia Di Vara
    Stefano Vicari
    European Archives of Psychiatry and Clinical Neuroscience, 2022, 272 : 1437 - 1442
  • [42] A long-term safety study of prolonged-release methylphenidate in adults with ADHD
    Schaeuble, B.
    Singh, J.
    Adler, L. A.
    Orman, C.
    Pandina, G. J.
    Palumbo, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S679 - S679
  • [43] Methylphenidate challenge test in adults with attention deficit/hyperactivity disorder (ADHD): Clinical effects and their predictors
    Piacentino, Daria
    De Rossi, Pietro
    Kotzalidis, Georgios D.
    Maniscalco, Ignazio
    Pompili, Maurizio
    Giupponi, Giancarlo
    Hiemke, Christoph
    Conca, Andreas
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2020, 35 (05)
  • [44] Effects of Maternal Symptom Ratings and Other Clinical Features on Short-Term Treatment Response to OROS Methylphenidate in Children and Adolescents with ADHD in a Naturalistic Clinical Setting
    Cop, Esra
    Oner, Ozgur
    Yurtbasi, Pinar
    Munir, Kerim
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 26 (02): : 126 - 133
  • [45] Change in Blood Cortisol Levels During 6-Month Methylphenidate Treatment in Children with ADHD
    Varmis, Dilek Altun
    Tahiroglu, Aysegul Yolga
    Kaypakli, Gamze Yapca
    Avci, Ayse
    Celik, Gonca Gul
    Metin, Ozge
    Matyar, Selcuk
    ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, 2020, 57 (02): : 49 - 58
  • [46] Outcomes of OROS® methylphenidate compared with atomoxetine in children with ADHD: A multicenter, randomized prospective study
    Jason E. Kemner
    H. Lynn Starr
    Patrick E. Ciccone
    Christa G. Hooper-Wood
    R. Steve Crockett
    Advances in Therapy, 2005, 22 : 498 - 512
  • [47] Effect of methylphenidate on functional controllability: a preliminary study in medication-naive children with ADHD
    Henry, Teague R. R.
    Fogleman, Nicholas D. D.
    Nugiel, Tehila
    Cohen, Jessica R. R.
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [48] COMPONENTS OF ATTENTION, METHYLPHENIDATE DOSAGE, AND BLOOD-LEVELS IN CHILDREN WITH ATTENTION-DEFICIT DISORDER
    SEBRECHTS, MM
    SHAYWITZ, SE
    SHAYWITZ, BA
    JATLOW, P
    ANDERSON, GM
    COHEN, DJ
    PEDIATRICS, 1986, 77 (02) : 222 - 228
  • [49] Outcomes of OROS® methylphenidate compared with atomoxetine in children with ADHD:: A multicenter, randomized prospective study
    Kemner, JE
    Starr, HL
    Ciccone, PE
    Hooper-Wood, CG
    Crockett, RS
    ADVANCES IN THERAPY, 2005, 22 (05) : 498 - 512
  • [50] Transition from immediate-release methylphenidate (ir-mph) to extended-release methylphenidate (OROS®-MPH) improves quality of life of patients with adhd -: a naturalistic study
    Hargarter, L.
    Gerwe, M.
    Czekalla, J.
    Mattejat, F.
    EUROPEAN PSYCHIATRY, 2007, 22 : S253 - S253